MedicineBiology

Rifaximin: a novel antimicrobial for enteric infections

David B. Huang, David B. Huang, H. Dupont

2005.2.1JOURNAL OF INFECTION

DOI: 10.1016/j.jinf.2004.05.019

tlooto Summary

Rifaximin shortens the duration of travelers' diarrhea and non-dysenteric diarrheal illness due to enterotoxigenic, enteroaggregative E. coli and Shigella sonnei without major alteration of aerobic fecal flora and without important side effects.

Abstract

Abstract is not available.

Citation format

HUANG, David B.; HUANG, David B.; DUPONT, H. Rifaximin: A novel antimicrobial for enteric infections. JOURNAL OF INFECTION, 2005, 50: 97–106.